Wei-Ching Liang Selected Research

Immunoglobulin G (IgG)

7/2004

VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Ching Liang Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 07/2004
2	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 12/2015
2	Breast Neoplasms (Breast Cancer) 06/2015 - 09/2008
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Bites and Stings (Sting) 01/2020
1	Disease Progression 01/2020
1	Geographic Atrophy 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Neuroblastoma 09/2008
1	Neoplasm Metastasis (Metastasis) 04/2008
1	Vascular Remodeling 01/2007
1	Colorectal Neoplasms (Colorectal Cancer) 03/2006
1	Fibrosarcoma 07/2004
1	Carcinogenesis 07/2004

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 01/2021 - 01/2006
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008 - 07/2004
3	Monoclonal AntibodiesIBA 09/2012 - 07/2004
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2015
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 06/2015
2	Neuropilin-1IBA 09/2012 - 01/2007
2	Blocking AntibodiesIBA 02/2007 - 01/2006
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Bispecific AntibodiesIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Interferon Type IIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Biological ProductsIBA 01/2020
1	HydrolasesIBA 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	TrypsinIBA 12/2015
1	Serine Proteases (Serine Protease)IBA 12/2015
1	vesencumabIBA 09/2012
1	Insulin-Like PeptidesIBA 09/2008
1	Docetaxel (Taxotere)FDA Link 09/2008
1	Antineoplastic Agents (Antineoplastics)IBA 09/2008
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2008
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 09/2008
1	LigandsIBA 09/2008
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 09/2008
1	Neuropilin-2IBA 04/2008
1	Vascular Endothelial Growth Factor CIBA 04/2008
1	Bevacizumab (Avastin)FDA Link 01/2006
1	Chemotactic FactorsIBA 07/2004
1	platelet-derived growth factor AIBA 07/2004
1	Immunoglobulin G (IgG)IBA 07/2004

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2007
3	Immunotherapy 01/2021 - 01/2020